Search Results - "Andreadou, E."

Refine Results
  1. 1

    Copper(I) halide complexes of N-methylbenzothiazole-2-thione: Synthesis, structure, luminescence, antibacterial activity and interaction with DNA by Tsiaggali, M.A., Andreadou, E.G., Hatzidimitriou, A.G., Pantazaki, A.A., Aslanidis, P.

    Published in Journal of inorganic biochemistry (01-04-2013)
    “…The reactions of copper(I) halides, CuX (X=Cl, Br, I) with N-methylbenzothiazole-2-thione (mbtt), independent of the molar ration chosen (1:2 or 1:3), led to…”
    Get full text
    Journal Article
  2. 2

    A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes by Vakrakou, A G, Tzanetakos, D, Valsami, S, Grigoriou, E, Psarra, K, Tzartos, J, Anagnostouli, M, Andreadou, E, Evangelopoulos, M E, Koutsis, G, Chrysovitsanou, C, Gialafos, E, Dimitrakopoulos, A, Stefanis, L, Kilidireas, C

    Published in BMC neurology (29-10-2018)
    “…Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Pulsed corticosteroid treatment in MS patients stabilizes disease activity following natalizumab withdrawal prior to switching to fingolimod by Evangelopoulos, M. E., Koutoulidis, V., Andreadou, E., Evangelopoulos, D. S., Kilidireas, C.

    Published in International journal of neuroscience (01-12-2016)
    “…Purpose: Interruption of natalizumab (NTM) treatment in multiple sclerosis (MS) patients may be followed by disease reactivation. On the other hand, patients…”
    Get full text
    Journal Article
  5. 5

    Circulating interleukin-10 and interleukin-12 in Parkinson's disease by Rentzos, M., Nikolaou, C., Andreadou, E., Paraskevas, G. P., Rombos, A., Zoga, M., Tsoutsou, A., Boufidou, F., Kapaki, E., Vassilopoulos, D.

    Published in Acta neurologica Scandinavica (01-05-2009)
    “…Background –  Interleukin (IL)‐12 is a heterodimeric cytokine produced by activated blood monocytes, macrophages and glial cells. It enhances differentiation…”
    Get full text
    Journal Article
  6. 6

    Circulating interleukin-15 and RANTES chemokine in Parkinson's disease by Rentzos, M., Nikolaou, C., Andreadou, E., Paraskevas, G. P., Rombos, A., Zoga, M., Tsoutsou, A., Boufidou, F., Kapaki, E., Vassilopoulos, D.

    Published in Acta neurologica Scandinavica (01-12-2007)
    “…Interleukin‐15 promotes T‐cell proliferation, induction of cytolytic effector cells including natural killer (NK) and cytotoxic cells and stimulates B‐cell to…”
    Get full text
    Journal Article
  7. 7

    Demyelinating Disease following Anti-TNFa Treatment : A Causal or Coincidental Association? Report of Four Cases and Review of the Literature by Andreadou, Elisabeth, Kemanetzoglou, E., Brokalaki, Ch, Evangelopoulos, Maria-Eleftheria, Kilidireas, Costas, Rombos, A., Stamboulis, E.

    Published in Case reports in neurological medicine (01-01-2013)
    “…Tumor necrosis factor antagonists (anti-TNFa) are an established therapeutic option for several autoimmune and inflammatory bowel diseases. Despite their…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Differential Expression of Cytokines and Chemokines in Human Monocytes Induced by Lipid Formulations of Amphotericin B by SIMITSOPOULOU, M, ROILIDES, E, DOTIS, J, DALAKIOURIDOU, M, DUDKOVA, F, ANDREADOU, E, WALSH, T. J

    Published in Antimicrobial Agents and Chemotherapy (01-04-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  10. 10

    CSF biomarker profile and diagnostic value in vascular dementia by Paraskevas, G. P., Kapaki, E., Papageorgiou, S. G., Kalfakis, N., Andreadou, E., Zalonis, I., Vassilopoulos, D.

    Published in European journal of neurology (01-02-2009)
    “…Background and purpose:  The differential diagnosis between vascular dementia (VD) and Alzheimer’s disease (AD) or mixed dementia (MD) is not always easy in…”
    Get full text
    Journal Article
  11. 11

    Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis by Andreadou, E, Chatzipanagiotou, S, Constantinides, V.C, Rombos, A, Stamboulis, E, Nicolaou, C

    Published in Clinical neurology and neurosurgery (01-10-2013)
    “…Abstract Lower prevalence of cerebrospinal fluid oligoclonal IgG bands (IgG-OCBs) has been reported in multiple sclerosis (MS) patients from Southern Europe…”
    Get full text
    Journal Article
  12. 12

    Anti-myelin-associated glycoprotein polyneuropathy coexistent with CREST syndrome by Andreadou, E, Zouvelou, V, Karandreas, N, Kilidireas, C

    Published in Journal of postgraduate medicine (01-01-2012)
    “…Clinical involvement of the peripheral nervous system in the calcinosis cutis, raynaud's phenomenon, esophageal dismotility, sclerodactyly and telangiectasia…”
    Get full text
    Journal Article
  13. 13

    Intermittent Atrioventricular Block following Fingolimod Initiation by Gerakoulis, S., Haina, V., Gialafos, E., Andreadou, Elisabeth, Stamboulis, E., Kilidireas, Costas, Grigoriou, A.

    Published in Case reports in neurological medicine (01-01-2014)
    “…A 47-year-old female patient with multiple sclerosis (MS) developed symptomatic intermittent 2nd degree atrioventricular block (AVB) of five-hour duration,…”
    Get full text
    Journal Article
  14. 14

    Stiff person syndrome: avoiding misdiagnosis by Andreadou, E, Kattoulas, E, Sfagos, C, Vassilopoulos, D

    Published in Neurological sciences (01-03-2007)
    “…Stiff person syndrome (SPS) is a rare neurological disorder characterised by muscular rigidity and superimposed spasms of the trunk and limbs that may be…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The onset of multiple sclerosis in Greece: a single-center study of 1,034 consecutive patients by Koutsis, G, Evangelopoulos, M E, Andreadou, E, Mandellos, D, Karachalios, G, Potagas, C, Karantoni, E, Karouli, M, Chrysovitsanou, C, Vassilopoulos, D, Sfagos, C

    Published in European neurology (01-01-2010)
    “…The onset of multiple sclerosis (MS) in Greece has not been systematically studied. We sought to provide data on the onset of MS in Greece with detailed…”
    Get more information
    Journal Article
  17. 17

    Neuromyelitis Optica Spectrum Disease with Positive Autoimmune Indices: A Case Report and Review of the Literature by Andreadou, E., Evangelopoulos, Maria-Eleftheria, Sfagos, C., Dimirakopoulos, A., Potagas, C., Koutsis, G.

    Published in Case Reports in Medicine (01-01-2011)
    “…A 45-year-old female suffering from severe thoracic pain was admitted to the emergency department of our hospital. Thorough clinical examination revealed…”
    Get full text
    Journal Article
  18. 18

    Silver(I) complexes of N-methylbenzothiazole-2-thione: Synthesis, structures and antibacterial activity by Aslanidis, P., Hatzidimitriou, A.G., Andreadou, E.G., Pantazaki, A.A., Voulgarakis, N.

    Published in Materials Science & Engineering C (01-05-2015)
    “…Three silver(I) complexes containing N-methylbenzothiazole-2-thione (mbtt) have been prepared and structurally characterized by X-ray single-crystal analysis…”
    Get full text
    Journal Article
  19. 19

    Frontal lobe dysfunction in amyotrophic lateral sclerosis by Evdokimidis, I, Constantinidis, T.S, Gourtzelidis, P, Smyrnis, N, Zalonis, I, Zis, P.V, Andreadou, E, Papageorgiou, C

    Published in Journal of the neurological sciences (15-03-2002)
    “…The aim of the present study was to investigate the involvement of frontal lobe dysfunction in amyotrophic lateral sclerosis (ALS) using ocular motor paradigms…”
    Get full text
    Journal Article
  20. 20

    ADVANCES IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) by Andreadou, E

    Published in Anticancer research (01-10-2008)
    “…Motor neurone disease or amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that specifically affects upper and lower motor…”
    Get full text
    Journal Article